¿Deben indicarse trombolíticos a los ancianos mayores de 75 años con síndrome coronario agudo y supradesnivel del ST? (Agonista)

Trongé, Jorge.
Rev. argent. cardiol ; 72(1): 52-55, ene.-feb. 2004. tab
Artículo en Español | LILACS | ID: lil-389401

Documentos relacionados

  1. Advances in Nano-Functional Materials in Targeted Thrombolytic Drug Delivery.
  2. Perioperative management of antithrombotics in elective intracranial procedures: systematic review, critical appraisal.
  3. Patient's Perceptions of Importance of Discontinuing Antithrombotic Medication Before Oculoplastics Surgery.
  4. Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved Indications.
  5. In ischemic stroke, adding IV thrombolysis ≤2 h after symptom onset to thrombectomy was associated with benefit.
  6. Prophylactic clipping for patients using oral antithrombotic agents: an individualized strategy is needed.
  7. Reteplase versus Alteplase for Acute Ischemic Stroke.
  8. Influence of Steric Shield on Biocompatibility and Antithrombotic Activity of Dendritic Polyphosphate Inhibitor.
  9. Dual antithrombotic treatment in chronic coronary syndrome: European Society of Cardiology criteria vs. CHADS-P2A2RC score.
  10. A systematic critical appraisal of clinical practice guidelines of antithrombotic agents in gastrointestinal endoscopy using the AGREE II tool.